Search - tctmd.com

Displaying 321 - 340 of 392

Sort: Relevancy | Date

News Conference News AHA 2016

AHA/ACC Issue Updated PAD Guidelines

L.A. McKeown

November 14, 2016

News Conference News AHA 2016

Ticagrelor Fails to Best Clopidogrel in Preventing CV Events in PAD Patients

Yael L. Maxwell

November 13, 2016

News Conference News AHA 2016

AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR

Shelley Wood

November 09, 2016

Presentation TCT 2016

Hybrid Surgical Approaches Offer the Best Options for Complex PAD: Case Examples

Presenter: Jihad A. Mustapha, Craig M. Walker, Koen Deloose

November 01, 2016

Presentation TCT 2016

Safety and Performance of the Shockwave Medical Lithoplasty System in Treating Calcified Peripheral Vascular Lesions: 6-Month Results from the Two-Phase DISRUPT PAD Study

Presenter: Michael D. Dake, Kenneth Rosenfield, Todd J. Brinton

November 01, 2016

Presentation TCT 2016

Results of the FIH Chocolate Touch Drug Coated Balloon Catheter for PAD: The ENDURE Trial

Presenter: Michael D. Dake, Kenneth Rosenfield, Mehdi H. Shishehbor

November 01, 2016

News Daily News

Según los Investigadores, Contemplar de Embolismo Pulmonar por Síncope Inexplicado es ‘Absolutamente Obligatorio.’

Michael O'Riordan

October 24, 2016

News Daily News

Considering Pulmonary Embolism for Unexplained Syncope Is ‘Absolutely Mandatory,’ Investigators Say

Michael O'Riordan

October 24, 2016

News Daily News

Red Meat and Dairy Gut Metabolite Linked to Higher Mortality in PAD Patients

Michael O'Riordan

October 20, 2016

News Conference News VIVA 2016

Longer Term, IN.PACT SFA Trial and Global Registry Continue to Support DCB Therapy as an Option

L.A. McKeown

October 12, 2016

News Daily News

EUCLID:替卡格雷相比氯吡格雷对有症状 PAD 患者预防心血管事件没有更大的好处

Shelley Wood

October 07, 2016

News Daily News

EUCLID: Ticagrelor Holds No Edge Over Clopidogrel for Preventing Atherothrombotic Events in Symptomatic PAD Patients

Shelley Wood

October 07, 2016

News Conference News VIVA 2016

Long PAD Lesions Respond Well to DCB, but Optimal Patient Selection Still Unclear

L.A. McKeown

September 21, 2016

News Conference News VIVA 2016

Positive Results Continue at 2 Years for Paclitaxel-Eluting PAD Stent

L.A. McKeown

September 20, 2016

News Industry News

Shockwave Medical Announces FDA Clearance of the Company’s Lithoplasty® System, the First and Only Technology to Use Sound Waves to Treat Calcified Peripheral Artery Disease

September 16, 2016

News Daily News

Drug-Coated Balloon Gets Expanded Indication for In-Stent Restenosis in PAD

Todd Neale

September 13, 2016

News Industry News

GORE® TIGRIS® Vascular Stent Gains FDA Approval for Treatment of Peripheral Artery Disease

August 02, 2016

Presentation CCVVC 2016

New technologies for the treatment of PAD: What’s happening outside the US?

Presenter: Jos C. van den Berg

June 15, 2016

News Daily News

Statins Tied to Lower Mortality, Amputation Risks in PAD

Michael O'Riordan

May 09, 2016

News Daily News

Potential Benefits of Drug-Coated Balloons for Infrapopliteal Disease Remain Uncertain

Todd Neale

April 28, 2016

Advertisement

AHA/ACC Issue Updated PAD Guidelines

Ticagrelor Fails to Best Clopidogrel in Preventing CV Events in PAD Patients

AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR

Hybrid Surgical Approaches Offer the Best Options for Complex PAD: Case Examples

Safety and Performance of the Shockwave Medical Lithoplasty System in Treating Calcified Peripheral Vascular Lesions: 6-Month Results from the Two-Phase DISRUPT PAD Study

Results of the FIH Chocolate Touch Drug Coated Balloon Catheter for PAD: The ENDURE Trial

Según los Investigadores, Contemplar de Embolismo Pulmonar por Síncope Inexplicado es ‘Absolutamente Obligatorio.’

Considering Pulmonary Embolism for Unexplained Syncope Is ‘Absolutely Mandatory,’ Investigators Say

Red Meat and Dairy Gut Metabolite Linked to Higher Mortality in PAD Patients

Longer Term, IN.PACT SFA Trial and Global Registry Continue to Support DCB Therapy as an Option

EUCLID:替卡格雷相比氯吡格雷对有症状 PAD 患者预防心血管事件没有更大的好处

EUCLID: Ticagrelor Holds No Edge Over Clopidogrel for Preventing Atherothrombotic Events in Symptomatic PAD Patients

Long PAD Lesions Respond Well to DCB, but Optimal Patient Selection Still Unclear

Positive Results Continue at 2 Years for Paclitaxel-Eluting PAD Stent

Shockwave Medical Announces FDA Clearance of the Company’s Lithoplasty® System, the First and Only Technology to Use Sound Waves to Treat Calcified Peripheral Artery Disease

Drug-Coated Balloon Gets Expanded Indication for In-Stent Restenosis in PAD

GORE® TIGRIS® Vascular Stent Gains FDA Approval for Treatment of Peripheral Artery Disease

New technologies for the treatment of PAD: What’s happening outside the US?

Statins Tied to Lower Mortality, Amputation Risks in PAD

Potential Benefits of Drug-Coated Balloons for Infrapopliteal Disease Remain Uncertain

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content